MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Net Income
-77.02M -73.47M -61.92M -55.18M -47.2M -38.95M -26.61M -17.77M -7.61M
Depreciation & Amortization
-769K 273K 244K 227K 192K 168K 120K 79K 39K
Stock-Based Compensation
6.46M 4.52M 2.68M 2.21M 1.61M 1.61M 1.61M 596K n/a
Other Working Capital
341K 2.87M 670K -604K 388K -1.58M -1.54M 1M -529K
Other Non-Cash Items
-3.14M -2.74M -280K 584K 1.15M 734K -411K 95K 86K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
3.66M 4.76M 4.6M 2.37M 1.39M -528K -962K 1.89M 102K
Operating Cash Flow
-70.81M -66.65M -54.68M -49.79M -42.85M -36.96M -26.25M -15.11M -7.38M
Capital Expenditures
-886K -631K -874K -837K -802K -381K -108K -53K -31K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-321.56M -289.82M -239.47M -185.87M -78.72M -63.03M -54.48M -20.58M n/a
Sales Maturities Of Investments
177.52M 112.65M 79.75M 64.5M 39.5M 51.25M 27M 22M 20M
Other Investing Acitivies
6M 5M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-138.92M -172.8M -160.59M -122.2M -40.02M -12.16M -27.59M 1.36M 19.97M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.71M -1.71M -1.71M 19K 19K 19K 19K n/a n/a
Financial Cash Flow
237.01M 233.93M 234.1M 234.25M 66.94M 69.33M 69.15M 69.13M 634K
Net Cash Flow
27.28M -5.52M 49.35M 92.78M 14.59M 37.51M 2.08M 42.16M n/a
Free Cash Flow
-71.7M -67.28M -55.55M -50.63M -43.65M -37.34M -26.36M -15.16M -7.41M